Citadel Advisors’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$178K Buy
+23,003
New +$178K ﹤0.01% 5049
2025
Q1
Sell
-267,353
Closed -$3.56M 5934
2024
Q4
$3.56M Buy
267,353
+6,873
+3% +$91.5K ﹤0.01% 2074
2024
Q3
$2.12M Hold
260,480
﹤0.01% 2458
2024
Q2
$2.21M Sell
260,480
-3
-0% -$26 ﹤0.01% 2347
2024
Q1
$4.52M Buy
260,483
+249,961
+2,376% +$4.34M ﹤0.01% 1824
2023
Q4
$135K Sell
10,522
-56,324
-84% -$722K ﹤0.01% 4773
2023
Q3
$2.47M Buy
66,846
+21,515
+47% +$796K ﹤0.01% 2208
2023
Q2
$1.82M Sell
45,331
-44,738
-50% -$1.8M ﹤0.01% 2498
2023
Q1
$6.53M Buy
90,069
+34,158
+61% +$2.48M ﹤0.01% 1613
2022
Q4
$4.58M Buy
55,911
+54,648
+4,327% +$4.48M ﹤0.01% 1857
2022
Q3
$119K Buy
1,263
+113
+10% +$10.6K ﹤0.01% 5048
2022
Q2
$224K Sell
1,150
-4,240
-79% -$826K ﹤0.01% 4905
2022
Q1
$1.25M Buy
5,390
+2,641
+96% +$613K ﹤0.01% 3526
2021
Q4
$1.08M Buy
2,749
+1,447
+111% +$570K ﹤0.01% 3729
2021
Q3
$583K Buy
1,302
+748
+135% +$335K ﹤0.01% 4367
2021
Q2
$215K Sell
554
-8,018
-94% -$3.11M ﹤0.01% 5511
2021
Q1
$3.08M Sell
8,572
-2,412
-22% -$866K ﹤0.01% 2695
2020
Q4
$5.39M Sell
10,984
-7,421
-40% -$3.64M ﹤0.01% 1706
2020
Q3
$5.96M Buy
18,405
+14,270
+345% +$4.62M ﹤0.01% 1394
2020
Q2
$1.51M Sell
4,135
-10,761
-72% -$3.92M ﹤0.01% 2485
2020
Q1
$3.17M Buy
14,896
+4,659
+46% +$991K ﹤0.01% 1811
2019
Q4
$4.22M Sell
10,237
-15,497
-60% -$6.38M ﹤0.01% 1756
2019
Q3
$9.08M Buy
25,734
+14,491
+129% +$5.12M ﹤0.01% 1251
2019
Q2
$5.65M Buy
11,243
+10,630
+1,734% +$5.34M ﹤0.01% 1569
2019
Q1
$609K Buy
+613
New +$609K ﹤0.01% 3231
2018
Q4
Hold
0
4486
2018
Q3
Sell
-227
Closed -$209K 4265
2018
Q2
$209K Sell
227
-592
-72% -$545K ﹤0.01% 3659
2018
Q1
$799K Buy
+819
New +$799K ﹤0.01% 2615
2017
Q3
Sell
-1,458
Closed -$510K 3646
2017
Q2
$510K Sell
1,458
-1,085
-43% -$380K ﹤0.01% 2577
2017
Q1
$1.31M Buy
+2,543
New +$1.31M ﹤0.01% 1927
2015
Q4
Sell
-355
Closed -$279K 3893
2015
Q3
$279K Buy
+355
New +$279K ﹤0.01% 2985